Summary
Platelet-rich plasma (PRP) containing platelets labelled with 14C-serotonin was used to characterize the release reaction. Heparin promotes release,
and the reduced release response to epinephrine observed in heparinized compared to
citrated PRP is probably due to the earlier reaction. The release reaction can occur
in citrated PRP at pH 7.0, is marked between pH 7.2 and 7.6, and decreases above pH
8.0. It is retained better when PRP is stored below pH 7.7. Adenosine, prostaglandin
E1, and theophylline inhibit both aggregation and release, probably because they elevate
cyclic AMP. D- and L-tosyl-phenylalanine chloromethylketone (TPCK) also inhibit both
aggregation and release at a concentration of 0.1 mM whereas 0.1 mM D- and l-L-chloro-2-tosylamido-7-amino-2-heptanone
(TLCK) and 5 mM diisopropylfluoro-phosphate (DFP), like aspirin, inhibit only release.
Colchicine (0.1 mM) alters platelet shape but does not affect release or aggregation.
Centrifugation of PRP at 37° C causes release which responds to inhibitors and pH
changes in a manner similar to release induced by aggregation with ADP or epinephrine.
Release occurs in thromb-asthenic platelets centrifuged at 37° C and is increased
by epinephrine. Release of ATP and ADP correlates significantly with release of 14C-serotonin. Thrombin plus CaCl2 causes release of β-glucuronidase but not of zinc.